**Core Concept:** Management of cervical cancer involves a multi-disciplinary approach, considering factors such as stage, grade, and patient's overall health status. Treatment options include surgery, radiation therapy, chemotherapy, and hormonal therapy, among others.

**Why the Correct Answer is Right:**
In this case, the patient is a 45-year-old female diagnosed with cervical carcinoma stage IIIB. Stage IIIB cervical cancer involves both the parametrial invasion and involvement of one or more pelvic lymph nodes. The best line of management in this scenario would involve a combination of modalities to achieve local control and systemic therapy to target the cancer cells that have spread to the lymph nodes.

**Why Each Wrong Option is Incorrect:**
A. **Option A (Surgery alone):** Surgery alone may not be sufficient for a stage IIIB cervical cancer patient, as the disease has already spread to pelvic lymph nodes and parametrial invasion.
B. **Option B (Chemotherapy alone):** Chemotherapy is essential in the management of cervical cancer but may not be sufficient in this stage as it does not address the local control provided by radiation therapy.
C. **Option C (Hormonal therapy):** Hormonal therapy is usually reserved for hormone-dependent tumors and may not be effective for this stage of cervical cancer.
D. **Option D (Single modality):** A multimodality approach is preferred in stage IIIB cervical cancer due to the involvement of parametrial invasion and pelvic lymph nodes, which requires a combination of radiation therapy, chemotherapy, and surgery.

**Clinical Pearl:**
In the management of stage IIIB cervical cancer, a combination of radiation therapy, chemotherapy, and surgery is the preferred approach to achieve optimal local control and systemic therapy. This multimodality approach addresses both the primary tumor control and the involvement of pelvic lymph nodes.

**Correct Answer:** Option D (Multimodality Approach)

A multimodality approach, including radiation therapy, chemotherapy, and surgery, is the preferred management strategy for a patient with stage IIIB cervical cancer. This combined approach ensures both local control of the primary tumor and systemic therapy for addressing the involvement of pelvic lymph nodes and parametrial invasion.